Receptors, Neurokinin-3, antagonists & inhibitors

All categories
Name
Receptors, Neurokinin-3, antagonists & inhibitors
Accession Number
DBCAT001804
Description

Not Available

Drugs
DrugDrug Description
TalnetantInvestigated for use/treatment in schizophrenia and schizoaffective disorders, irritable bowel syndrome (IBS), and chronic obstructive pulmonary disease (COPD).
PavinetantPavinetant has been used in trials studying the basic science and treatment of Safety and Schizophrenia.
Sar9, Met (O2)11-Substance PInvestigated for use/treatment in acute respiratory distress syndrome (ARDS) and viral infection.
Drugs & Drug Targets
DrugTargetType
TalnetantNeuromedin-K receptortarget
PavinetantNeuromedin-K receptortarget
Sar9, Met (O2)11-Substance PCytochrome P450 19A1enzyme
Sar9, Met (O2)11-Substance PCholinesteraseenzyme
Sar9, Met (O2)11-Substance PProstaglandin G/H synthase 2enzyme